ČŐ±ľÎŢÂë

Dans cette section :

Anémie – hémorragie (Affections liées aux soins de santé ou aux médicaments) : Références

Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M, ComitĂ© des lignes directrices sur la fibrillation auriculaire du CCS. «ĚýCanadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.Ěý» Cn J Cardiol. 2011; 27 (1), 74-90. DOI: 10.1016/j.cjca.2010.11.007.

Carnovale C, Brusadelli T, Casini ML. «ĚýDrug-induced anaemia: a decade review of reporting to the Italian Pharmacovigilance data-base.Ěý» Int Clin J Pharm. 2015, 37 (1), 23-26. DOI: 10.1007/s11096-014-0054-3

Christos S, Naples R. «ĚýAnticoagulation reversal and treatment strategies in major bleeding: Update 2016.Ěý» West J Emerg Med. 2016; 17 (3): 264-70. DOI: 10.5811/westjem.2016.3.29294.

Cousins D, Harris, Safe Medication Practice Team. Risk assessment of anticoagulation therapy. National Patient Safety Agency; 2006.

Fernández CS, Formiga F, Camafort M, et al. «ĚýAntithrombotic treatment in elderly patients with atrial fibrillation: a practical approach.Ěý» BMC Cardiovasc Disord. 2015; 15: 143. doi: 10.1186/s12872-015-0137-7.

Guillamondegui OD, Gunter OL Jr, EAST Practice Management Guidelines Committee (comité des lignes directrices sur la gestion de la pratique). Practice management guidelines for stress ulcer prophylaxis. Chicago, IL: Eastern Association for the Surgery of Trauma; 2008.

Herzig SJ, Rothberg MB, Feinbloom DB, et al. «ĚýRisk factors for nosocomial gastrointestinal bleeding and use of acid-suppressive medication in non-critically ill patients.Ěý» J Gen Intern Med. 2013; 28 (5): 683-690. doi: 10.1007/s11606-012-2296-x.

Institute for Healthcare Improvement (IHI). Changes: Reduce adverse drug events involving anticoagulants. Cambridge, MA: IHI; 2020b.

Institute for Healthcare Improvement (IHI). Educate Patients to Manage Warfarin Therapy at Home. Cambridge, MA: IHI; 2020a. http://www.ihi.org/resources/Pages/Changes/EducatePatientstoManageWarfarinTherapyatHome.aspx

Institute for Healthcare Improvement (IHI). How-to guide: prevent harm from high-alert medications. Cambridge, MA: IHI; 2012.

Institut pour l'utilisation sécuritaire des médicaments (ISMP). Document de l'ISMP intitulé High-alert medications in acute care settings. Horsham, PA; ISMP: 2018. https://www.ismp.org/sites/default/files/attachments/2018-08/highAlert2018-Acute-Final.pdf

Lanza FL, Chan FK, Quigley EM. «ĚýGuidelines for prevention of NSAID-related ulcer complications.Ěý» Am J Gastroenterol. 2009; 104 (3), 728-738. doi: 10.1038/ajg.2009.115.

Lichtin AE. «ĚýEtiology of anemia.Ěý» Merck Manual. 2017.

McEvoy MT, Shander A. «ĚýAnemia, bleeding, and blood transfusion in the intensive care unit: causes, risks, costs, and new strategies.Ěý» Am J Crit Care. 2013; 22 (6 Suppl): eS1-13. DOI: 10.4037/ajcc2013729.

Narum S, Westergren T, Klemp M. «ĚýCorticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis.Ěý» BMJ Open. 2014, 4 (5): e004587. DOI: 10.1136/bmjopen-2013-004587.Ěý

Rectificatif : Rectificatif de Fernández CS, Formiga F, Camafort M, et al. : «ĚýAntithrombotic treatment in elderly patients with atrial fibrillation: a practical approach.Ěý» BMC Cardiovasc Disord. 2015; 15: 157. doi: 10.1186/s12872-015-0150-x.

Université Purdue, programme PharmaTAP. Anticoagulant tool kit: Reducing adverse drug events & potential adverse drug events with unfractionated heparin, low molecular weight heparins and warfarin. Indianapolis, IN : Université Purdue, PharmaTAP : 2008.

Weinhouse GL. «ĚýStress ulcer prophylaxis in the intensive care unit.Ěý» UpToDate. 2018.

Ěý

image_banner
Anémie – hémorragie (Affections liées aux soins de santé ou aux médicaments)

Retour au sommaire

image_banner
Anémie – hémorragie (Affections liées aux soins de santé ou aux médicaments)

Retour au sommaire